 |
|
Ascorbic Acid and the Common ColdEvaluation of Its Efficacy and Toxicity
Michael H. M. Dykes, MD;
Paul Meier, PhD
JAMA. 1975;231(10):1073-1079.
Abstract
We reviewed the clinical data relating to the efficacy and safety of pharmacologic doses of ascorbic acid in the prevention and treatment of the common cold. Although one study tentatively supports the hypothesis that such doses of ascorbic acid may be efficacious, a second study by the same group did not confirm the significant findings, and no clear, reproducible pattern of efficacy has emerged from the review of all the evidence. Similarly, there is currently little adequate evidence on either the presence or the absence of serious adverse reactions to such doses of ascorbic acid, although many such reactions have been hypothesized. The unrestricted use of ascorbic acid for these purposes cannot be advocated on the basis of the evidence currently available.
(JAMA 231:1073-1079, 1975)
Author Affiliations
Dr. Dykes is Senior Scientist, AMA Department of Drugs. Dr. Meier is Professor, departments of statistics and pharmacological and physiological sciences, University of Chicago.
Footnotes
Reprint requests to Department of Drugs, American Medical Association, 535 N Dearborn St, Chicago, IL 60610 (Dr. Dykes).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
The Plausibility of Micronutrient Deficiency in Relationship to Perinatal Infection
Goldenberg
J. Nutr. 2003;133:1645S-1648.
ABSTRACT
| FULL TEXT
Nutrients and their role in host resistance to infection
Field et al.
J. Leukoc. Biol. 2002;71:16-32.
ABSTRACT
| FULL TEXT
Use of Nutritional Supplements by Family Practice Patients
English and Carl
JAMA 1981;246:2719-2721.
ABSTRACT
Vitamin C Prophylaxis in Marine Recruits
Pitt and Costrini
JAMA 1979;241:908-911.
ABSTRACT
|
